Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis

Osteoarthritis Clinical Trial

Official title:

Synvisc® in Knee Osteoarthritis: Retrospective Follow-up in Treated Patients Since at Least Three Years

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02195557
• Other study ID #: 1139.6
• Status: Completed
• Phase: N/A
• First received: July 18, 2014
• Last updated: July 21, 2014
• Start date: April 2002

Study information

• Verified date: July 2014
• Source: Boehringer Ingelheim
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: The Commission nationale de l’informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Retrospective collection of data, aimed at a better knowledge of the use of Synvisc® among the patients with knee osteoarthritis (OA) since at least three years.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. primary completion date: March 2003
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with knee osteoarthritis using Synvisc® since at least three years

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Drug:
• Synvisc®

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Boehringer Ingelheim

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reason for prescription		at least 3 years before start of observation period	Yes
Primary	Number of other treatments per patient	antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs), specific symptomatic treatments and surgery	at least 3 years of observation	No
Primary	Time between two treatments		at least 3 years of observation	No

External Links

•   Link